Skip to Content

APR 30 (Otezla 30 mg)

Generic Name: apremilast

Pill with imprint APR 30 is Beige, Four-sided and has been identified as Otezla 30 mg. It is supplied by Celgene Corporation.

Otezla is used in the treatment of plaque psoriasis; psoriatic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Otezla 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APR 30

Otezla

Generic Name:
apremilast
Imprint:
APR 30
Strength:
30 mg
Color:
Beige
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Antirheumatics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Celgene Corporation
National Drug Code (NDC):
59572-0630

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide